X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ORIC

Closed

Oric Pharmaceuticals inc

10.14
-0.01 (-0.10%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 10.15
Day's Range: 9.8 - 10.33
Send
When Written:
 
5.79
Oric Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that focuses on developing therapies for cancer treatment. The company is based in Durham, North Carolina, and was founded in 2014. Oric Pharmaceuticals aims to develop novel treatments for cancer patients by targeting specific cancer cell signaling pathways. The company's lead product candidate, ORIC-101, is a small molecule inhibitor of the glucocorticoid receptor that is being evaluated in clinical trials for the treatment of solid tumors. Oric Pharmaceuticals has also developed a pipeline of other product candidates that target other cancer cell signaling pathways. The company has partnerships with several academic institutions and pharmaceutical companies to advance its research and development efforts.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X